Head of Neuropsychiatry Development
Dr. Ilya Reznik is a Board-certified specialist in Adult Forensic & Clinical NeuroPsychiatry at MaReNa Diagnostic and Consulting Center, Israel.
Dr. Ilya Reznik has superior educational and professional record and documented contributions to the field of neuropsychiatric research, such as publications and other innovative activities. Dr. Reznik has published many original papers (including controlled trials), reviews and case reports in leading peer-reviewed journals in field of clinical psychiatry and neuropsychopharmacology.
His current main interest is in the field of the medicinal use of cannabis and cannabinoids, especially for various neuropsychiatric illnesses, such as Chronic Pain Syndrome, Fibromyalgia, Post-Traumatic Stress Disorder (PTSD), Epilepsy, Head/Brain Injury, OCD, ADHD, Gilles de la Tourette syndrome, Chronic Headache, Parkinson’s and Alzheimer diseases etc.
During the last 12 years Dr. Reznik gained an extensive clinical & research experience working with cannabis and its products in NeuroPsychiatry and General & Complementary/Integrative Medicine. He coordinated the activity of Israel National Forum for Medical Cannabis Research & Treatment and served as a professional advisor (and permanent participant and observer) to Israeli Parilament (Knesset) Comeetetee for Drugs and Alcohol Control and to Parilamentary Public Lobby for Medicinal Cannabis.
Dr. Reznik is renowned International Speaker on Cannabinoid Medicine issues. He is Associate Member of The Canadian Consortium for the Investigation of Cannabinoids (CCIC) & of International Cannabinoid Research Society (ICRS). In 2013 he was elected to the Board of Directors, International Association for Cannabinoid Medicines (IACM).
In 2019 Dr. Ilya Reznik was appointed as an IACM Secretary for Partnership & Networking and promotes Educational and International activity within IACM.